Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 02:04PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.48 Insider Own42.71% Shs Outstand128.42M Perf Week-3.84%
Market Cap29.62M Forward P/E- EPS next Y-5.25 Insider Trans-2.09% Shs Float3.69M Perf Month-39.81%
Income-48.81M PEG- EPS next Q-1.50 Inst Own6.11% Short Float0.45% Perf Quarter-31.27%
Sales0.62M P/S47.77 EPS this Y35.92% Inst Trans- Short Ratio0.43 Perf Half Y-50.73%
Book/sh0.03 P/B138.73 EPS next Y12.84% ROA-114.91% Short Interest0.02M Perf Year-70.47%
Cash/sh4.34 P/C1.06 EPS next 5Y- ROE-3702.24% 52W Range4.23 - 16.12 Perf YTD-22.35%
Dividend Est.- P/FCF- EPS past 5Y-18.22% ROI-303.78% 52W High-71.43% Beta0.45
Dividend TTM- Quick Ratio1.22 Sales past 5Y50.93% Gross Margin-232.58% 52W Low8.89% ATR (14)0.55
Dividend Ex-Date- Current Ratio1.23 EPS Y/Y TTM-15.29% Oper. Margin-6296.77% RSI (14)31.42 Volatility8.31% 8.94%
Employees85 Debt/Eq7.62 Sales Y/Y TTM12.73% Profit Margin-7873.23% Recom1.00 Target Price99.00
Option/ShortNo / Yes LT Debt/Eq2.77 EPS Q/Q44.25% Payout- Rel Volume0.17 Prev Close4.63
Sales Surprise-55.08% EPS Surprise-12.50% Sales Q/Q-31.78% EarningsMay 08 BMO Avg Volume38.91K Price4.61
SMA20-21.46% SMA50-32.26% SMA200-42.71% Trades Volume4,768 Change-0.52%
Date Action Analyst Rating Change Price Target Change
Oct-04-22Downgrade Oppenheimer Outperform → Perform
Jul-18-22Initiated H.C. Wainwright Buy $16
May-02-22Initiated Canaccord Genuity Buy $10
Sep-28-21Initiated Oppenheimer Outperform $20
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-12-24 10:34AM
Jul-11-24 09:00AM
Jul-09-24 08:00AM
08:00AM Loading…
Jun-24-24 08:00AM
Jun-21-24 07:09AM
Jun-18-24 07:37AM
Jun-12-24 07:46AM
Jun-11-24 07:00AM
Jun-05-24 08:00AM
May-28-24 07:30AM
May-14-24 08:00AM
07:30AM Loading…
May-10-24 07:30AM
May-08-24 12:54PM
May-01-24 08:30AM
Apr-16-24 04:01PM
Mar-19-24 08:30AM
Mar-15-24 08:00AM
Mar-13-24 09:30AM
Mar-07-24 08:00AM
Feb-29-24 08:00AM
Feb-22-24 08:00AM
Feb-05-24 02:30PM
08:30AM Loading…
Jan-24-24 08:30AM
Jan-10-24 09:00AM
Jan-08-24 07:00AM
Jan-03-24 04:25PM
Dec-22-23 03:00PM
Dec-21-23 07:46AM
Dec-19-23 09:00AM
Dec-15-23 03:00PM
Dec-14-23 08:36AM
Dec-12-23 08:30AM
Dec-08-23 02:19PM
Nov-23-23 09:00AM
Nov-14-23 08:30AM
Nov-09-23 09:00AM
Nov-07-23 08:57AM
Oct-31-23 08:30AM
Oct-26-23 08:30AM
Oct-19-23 08:30AM
Oct-17-23 08:30AM
Oct-11-23 09:00AM
Oct-06-23 02:15PM
Oct-05-23 10:00AM
Sep-29-23 03:00PM
Sep-28-23 08:00AM
Sep-27-23 09:00AM
Sep-25-23 04:00PM
Aug-30-23 08:20AM
Aug-29-23 07:00AM
Aug-14-23 08:00AM
Aug-02-23 07:00AM
Jun-28-23 11:19AM
Jun-26-23 08:00AM
Jun-21-23 09:20AM
Jun-16-23 08:00AM
Jun-15-23 04:38PM
May-25-23 08:00AM
May-12-23 04:00PM
Apr-25-23 04:05PM
Apr-11-23 08:00AM
Mar-16-23 09:46AM
Mar-13-23 07:00AM
Mar-09-23 06:30AM
Mar-08-23 04:10PM
Mar-07-23 08:00AM
Mar-06-23 07:00AM
Feb-27-23 07:00AM
Feb-13-23 07:00AM
Jan-11-23 08:00AM
Dec-27-22 04:01PM
Dec-12-22 08:00AM
Nov-28-22 08:00AM
Nov-07-22 08:00AM
Oct-31-22 08:00AM
Oct-03-22 08:00AM
Sep-30-22 04:12PM
Sep-21-22 07:00AM
Aug-30-22 07:00AM
Aug-15-22 07:00AM
Aug-12-22 04:01PM
Jul-19-22 07:00AM
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
General Resonance LLC10% OwnerMay 01 '24Sale0.4013,0005,14815,313,712May 08 12:16 PM
General Resonance LLC10% OwnerApr 30 '24Sale0.4213,0005,41615,326,712May 08 12:16 PM
General Resonance LLC10% OwnerApr 24 '24Sale0.3310,0003,27815,349,712May 01 05:13 PM
General Resonance LLC10% OwnerApr 09 '24Sale0.3922,5008,67415,428,212Apr 16 09:38 AM
MATLIN DAVID JDirectorNov 10 '23Buy0.41250,002102,5017,043,686Nov 13 07:48 AM